Papers
Topics
Authors
Recent
2000 character limit reached

Overcoming Medical Overuse with AI Assistance: An Experimental Investigation (2405.10539v1)

Published 17 May 2024 in econ.EM, econ.GN, and q-fin.EC

Abstract: This study evaluates the effectiveness of AI in mitigating medical overtreatment, a significant issue characterized by unnecessary interventions that inflate healthcare costs and pose risks to patients. We conducted a lab-in-the-field experiment at a medical school, utilizing a novel medical prescription task, manipulating monetary incentives and the availability of AI assistance among medical students using a three-by-two factorial design. We tested three incentive schemes: Flat (constant pay regardless of treatment quantity), Progressive (pay increases with the number of treatments), and Regressive (penalties for overtreatment) to assess their influence on the adoption and effectiveness of AI assistance. Our findings demonstrate that AI significantly reduced overtreatment rates by up to 62% in the Regressive incentive conditions where (prospective) physician and patient interests were most aligned. Diagnostic accuracy improved by 17% to 37%, depending on the incentive scheme. Adoption of AI advice was high, with approximately half of the participants modifying their decisions based on AI input across all settings. For policy implications, we quantified the monetary (57%) and non-monetary (43%) incentives of overtreatment and highlighted AI's potential to mitigate non-monetary incentives and enhance social welfare. Our results provide valuable insights for healthcare administrators considering AI integration into healthcare systems.

Definition Search Book Streamline Icon: https://streamlinehq.com
References (65)
  1. \NAT@swatrue
  2. (2022). Power and prediction: The disruptive economics of artificial intelligence. Harvard Business Press. \NAT@swatrue
  3. (2023). Overuse of medications in low-and middle-income countries: a scoping review. Bulletin of the World Health Organization, 101(1), 36. \NAT@swatrue
  4. (2023). A review of the role of artificial intelligence in healthcare. Journal of personalized medicine, 13(6), 951. \NAT@swatrue
  5. (2024). Ai oversight and human mistakes: Evidence from centre court. arXiv preprint arXiv:2401.16754. \NAT@swatrue
  6. (2010). Physicians’ views on defensive medicine: a national survey. Archives of internal medicine, 170(12), 1081–1083. \NAT@swatrue
  7. (2006). A domain-specific risk-taking (dospert) scale for adult populations. Judgment and Decision making, 1(1), 33–47. \NAT@swatrue
  8. (2017). Evidence for overuse of medical services around the world. The Lancet, 390(10090), 156–168. \NAT@swatrue
  9. (2020). A systematic review of algorithm aversion in augmented decision making. Journal of behavioral decision making, 33(2), 220–239. \NAT@swatrue
  10. (1990). What one intelligence test measures: a theoretical account of the processing in the raven progressive matrices test. Psychological review, 97(3), 404. \NAT@swatrue
  11. (2018). Implementing machine learning in health care—addressing ethical challenges. The New England journal of medicine, 378(11), 981. \NAT@swatrue
  12. (1998). The urgent need to improve health care quality: Institute of medicine national roundtable on health care quality. Jama, 280(11), 1000–1005. \NAT@swatrue
  13. (2016). otree—an open-source platform for laboratory, online, and field experiments. Journal of Behavioral and Experimental Finance, 9, 88–97. \NAT@swatrue
  14. (2023). A framework for integrating artificial intelligence for clinical care with continuous therapeutic monitoring. Nature Biomedical Engineering, 1–10. \NAT@swatrue
  15. (2014). Do physicians’ financial incentives affect medical treatment and patient health? American Economic Review, 104(4), 1320–1349. \NAT@swatrue
  16. (2019). The potential for artificial intelligence in healthcare. Future healthcare journal, 6(2), 94. \NAT@swatrue
  17. (2015). Algorithm aversion: people erroneously avoid algorithms after seeing them err. Journal of Experimental Psychology: General, 144(1), 114. \NAT@swatrue
  18. (2018). Provider incentives and healthcare costs: Evidence from long-term care hospitals. Econometrica, 86(6), 2161–2219. \NAT@swatrue
  19. (2019). Artificial intelligence in health care: will the value match the hype? Jama, 321(23), 2281–2282. \NAT@swatrue
  20. (2012). The role of economic incentives in improving the quality of mental health care. In The elgar companion to health economics, second edition. Edward Elgar Publishing. \NAT@swatrue
  21. (2020). Design of financial incentives and payment schemes in healthcare systems: A review. Socio-Economic Planning Sciences, 72, 100901. \NAT@swatrue
  22. (2018). Global evidence on economic preferences. The quarterly journal of economics, 133(4), 1645–1692. \NAT@swatrue
  23. (2000). Rand/ucla appropriateness method user’s manual. RAND corporation Santa Monica, CA. \NAT@swatrue
  24. Frederick, S.  (2005). Cognitive reflection and decision making. Journal of Economic perspectives, 19(4), 25–42. \NAT@swatrue
  25. Glauser, W.  (2020). Ai in health care: Improving outcomes or threatening equity? Can Med Assoc. \NAT@swatrue
  26. (2020). Effects of monetary incentives in physician groups: a systematic review of reviews. Applied Health Economics and Health Policy, 18, 655–667. \NAT@swatrue
  27. (2021). Comparing burnout and work-life balance among specialists in internal medicine: the role of inpatient vs. outpatient workplace. Journal of Occupational Medicine and Toxicology, 16, 1–5. \NAT@swatrue
  28. (2022). Strengthening health systems using innovative digital health technologies in africa. Frontiers in Digital Health, 4, 854339. \NAT@swatrue
  29. (2022). The regulatory gap in digital health and alternative pathways to bridge it. Health Policy and Technology, 11(3), 100663. \NAT@swatrue
  30. (2019). Clinical practice guidelines and the overuse of health care services: need for reform. Cmaj, 191(11), E297–E298. \NAT@swatrue
  31. (2017). Artificial intelligence in healthcare: past, present and future. Stroke and vascular neurology, 2(4). \NAT@swatrue
  32. Kawaguchi, K.  (2021). When will workers follow an algorithm? a field experiment with a retail business. Management Science, 67(3), 1670–1695. \NAT@swatrue
  33. (2019). Key challenges for delivering clinical impact with artificial intelligence. BMC medicine, 17, 1–9. \NAT@swatrue
  34. (2012). Overuse of health care services in the united states: an understudied problem. Archives of internal medicine, 172(2), 171–178. \NAT@swatrue
  35. (2020). How are pay-for-performance schemes in healthcare designed in low-and middle-income countries? typology and systematic literature review. BMC Health Services Research, 20, 1–14. \NAT@swatrue
  36. (2024). When advanced ai isn’t enough: Human factors as drivers of success in generative ai-human collaborations. Available at SSRN 4738829. \NAT@swatrue
  37. (2018). The contribution of patients and providers to the overuse of prescription drugs (Tech. Rep.). National Bureau of Economic Research. \NAT@swatrue
  38. Lu, F.  (2014). Insurance coverage and agency problems in doctor prescriptions: evidence from a field experiment in china. Journal of Development Economics, 106, 156–167. \NAT@swatrue
  39. (2007). Impact of financial incentives on clinical autonomy and internal motivation in primary care: ethnographic study. Bmj, 334(7608), 1357. \NAT@swatrue
  40. (2017). Digital health is a cultural transformation of traditional healthcare. Mhealth, 3. \NAT@swatrue
  41. (2015). Setting a research agenda for medical overuse. Bmj, 351. \NAT@swatrue
  42. (2019). 2019 update on medical overuse: a review. JAMA internal medicine, 179(11), 1568–1574. \NAT@swatrue
  43. (2022). Overuse of diagnostic testing in healthcare: a systematic review. BMJ quality & safety, 31(1), 54–63. \NAT@swatrue
  44. (2019). Artificial intelligence in nephrology: core concepts, clinical applications, and perspectives. American Journal of Kidney Diseases, 74(6), 803–810. \NAT@swatrue
  45. (2016). Predicting the future—big data, machine learning, and clinical medicine. The New England journal of medicine, 375(13), 1216. \NAT@swatrue
  46. OpenAI.  (2023). Openai: An ai research and deployment company. https://www.openai.com. (Accessed: 2024-04-29) \NAT@swatrue
  47. (2012). Handbook of health economics (Vol. 2). Elsevier. \NAT@swatrue
  48. (2006). Does pay-for-performance improve the quality of health care? Annals of internal medicine, 145(4), 265–272. \NAT@swatrue
  49. (2012). Harnessing the power of enhanced data for healthcare quality improvement: lessons from a minnesota hospital association pilot project. Journal of Healthcare Management, 57(6), 406–418. \NAT@swatrue
  50. (1986). Doctors’ unawareness of the drugs their patients are taking: a major cause of overprescribing? Br Med J (clin res ed), 292(6513), 99–100. \NAT@swatrue
  51. (2020). Integrating artificial intelligence into the clinical practice of radiology: challenges and recommendations. European radiology, 30, 3576–3584. \NAT@swatrue
  52. (2002). Incentives in health care. Advances in health economics, 77–98. \NAT@swatrue
  53. (2022). Factors associated with overuse of health care within us health systems: a cross-sectional analysis of medicare beneficiaries from 2016 to 2018. In Jama health forum (Vol. 3, pp. e214543–e214543). \NAT@swatrue
  54. (2010). Burnout and medical errors among american surgeons. Annals of surgery, 251(6), 995–1000. \NAT@swatrue
  55. (2021). Health information technology and digital innovation for national learning health and care systems. The Lancet Digital Health, 3(6), e383–e396. \NAT@swatrue
  56. Summerton, N.  (1995). Positive and negative factors in defensive medicine: a questionnaire study of general practitioners. Bmj, 310(6971), 27–29. \NAT@swatrue
  57. Sung, J. J.  (2024). Artificial intelligence and the future of medicine. In Artificial intelligence in medicine (pp. 1–12). Elsevier. \NAT@swatrue
  58. Taleb, N. N.  (2014). Antifragile: Things that gain from disorder (Vol. 3). Random House Trade Paperbacks. \NAT@swatrue
  59. Topol, E. J.  (2019). High-performance medicine: the convergence of human and artificial intelligence. Nature medicine, 25(1), 44–56. \NAT@swatrue
  60. (2018). Factors associated with imaging overuse in the emergency department: a systematic review. The American journal of emergency medicine, 36(2), 301–309. \NAT@swatrue
  61. (2010). Systematic review: effects, design choices, and context of pay-for-performance in health care. BMC health services research, 10, 1–13. \NAT@swatrue
  62. (2019). Changing health behaviors using financial incentives: a review from behavioral economics. BMC public health, 19, 1–9. \NAT@swatrue
  63. (2019). Ai in health: state of the art, challenges, and future directions. Yearbook of medical informatics, 28(01), 016–026. \NAT@swatrue
  64. (2002). Geography and the debate over medicare reform: A reform proposal that addresses some underlying causes of medicare funding woes: geographic variation and lack of incentive for efficient medical practices. Health affairs, 21(Suppl1), W96–W112. \NAT@swatrue
  65. (2019). Does an economic incentive affect provider behavior? evidence from a field experiment on different payment mechanisms. Journal of medical economics, 22(1), 35–44.

Summary

We haven't generated a summary for this paper yet.

Whiteboard

Paper to Video (Beta)

Open Problems

We haven't generated a list of open problems mentioned in this paper yet.

Continue Learning

We haven't generated follow-up questions for this paper yet.

Collections

Sign up for free to add this paper to one or more collections.

Tweets

Sign up for free to view the 2 tweets with 0 likes about this paper.